Patient Guide: A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 45 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05389449
Status: ACTIVE_NOT_RECRUITING
Condition: Hemoglobinuria, Hemoglobinuria, Paroxysmal
Phase: PHASE3

Where You Can Participate

This study is available at 45 locations across the country.

Top locations include:
  • • Los Angeles, California
  • • Chicago, Illinois
  • • Baltimore, Maryland
  • • And 42 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH - Join Clinical Trial NCTNCT05389449

How to Join This Clinical Trial - NCTNCT05389449

Learn how to participate in this PHASE3 trial studying an investigational therapy for Hemoglobinuria, Hemoglobinuria, Paroxysmal. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hemoglobinuria, Hemoglobinuria, Paroxysmal. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hemoglobinuria, Hemoglobinuria, Paroxysmal
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05389449 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 45 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90089 - United States

Status: Contact for availability

Clinical Research Site

Chicago, Illinois 60612 - United States

Status: Contact for availability

Clinical Research Site

Baltimore, Maryland 21231 - United States

Status: Contact for availability

Clinical Research Site

Kansas City, Missouri 64111 - United States

Status: Contact for availability

Clinical Research Site

Long Island City, New York 11101 - United States

Status: Contact for availability

Clinical Research Site

Cleveland, Ohio 44195 - United States

Status: Contact for availability

Clinical Research Site

Dallas, Texas 75390-9047 - United States

Status: Contact for availability

Clinical Research Site

Porto Alegre, 90110-270 - Brazil

Status: Contact for availability

Clinical Research Site

Rio de Janeiro, 20211-080 - Brazil

Status: Contact for availability

Clinical Research Site

Toronto, Ontario M5G 2C4 - Canada

Status: Contact for availability

And 35 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Hemoglobinuria, Hemoglobinuria, Paroxysmal:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships